Keep Your Eyes on Stock News: Natera (NASDAQ:NTRA)

On Wednesday Natera (NASDAQ:NTRA) traded with change of -1.61% on volume of 520426 shares in the last session as compared to average volume of 722033 shares. During last trade its minimum price was $36.54 and it gained highest price of $37.74. NTRA has total market capitalization of $2777407198. Its closing value stands at $36.62.

On Nov. 6, 2019, Natera (NASDAQ:NTRA) a leader in non-invasive genetic testing and the analysis of circulating cell-free DNA, released financial results for the third quarter ended September 30, 2019 and provided an update on recent business progress.

Recent Accomplishments & Highlights

  • Generated total revenues of $77.9 million in the third quarter of 2019 compared to $65.3 million in the third quarter of 2018, an increase of 19%.
  • Processed over 200,000 tests in the third quarter of 2019, compared to approximately 167,000 tests processed in the third quarter of 2018, an increase of approximately 20%.
  • Processed approximately 136,000 Panorama tests in the third quarter of 2019, compared to approximately 106,000 Panorama tests processed in the third quarter of 2018, an increase of approximately 28%.
  • Accessioned approximately 55,000 Horizon carrier screening (HCS) tests in the third quarter of 2019 compared to approximately 44,000 HCS tests accessioned in the third quarter of 2018, an increase of approximately 25%.
  • Received positive draft local coverage decision from Medicare for reimbursement of Signatera™ in colorectal cancer.
  • Completed key technical and commercialization milestones with BGI Genomics.
  • Entered into partnership to develop and commercialize personalized circulating tumor DNA monitoring assays with Foundation Medicine.
  • Successfully completed $230 million follow-on equity offering.

Leave a Reply

Your email address will not be published. Required fields are marked *